Fighting Acne With Chitooligosaccharides
Acne is a common skin issues and occurs in 80% of those between the ages of 11 and 30. There are many factors associated with the occurrence of acne, such as bacteria, hormones, and the increased production of sebum. While acne is not life-threatening, it can have serious physical and emotional impacts, such as scarring and inflammation as well as insecurity, feeling antisocial, and even depression in some.
In the scientific community it is well known that the bacteria Staphylococcus epidermidis, Propionibacterium acnes, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans can all lead to abnormal follicular keratinization and inflammation of the skin. Among these, Propionibacterium acnes (P. Acnes) is a significant factor in the development of acne.
General Acne Treatment
When you have acne you look for a way to treat it. Some common treatments include retinoids, benzoyl peroxide, and antibiotics. These are used to manage symptoms and destroy the bacteria that cause acne. However, antibiotics and benzoyl peroxide have side effects, such as bacteria becoming resistant to drugs, eliminating “good” bacteria with the bad, and damaging tissue and organs with long-term use. These chemicals can also be harmful to the human cells.
So how do we treat acne when the best solution is to treat the cause?
Chitooligosaccharides in Resisting P. acnes
Scientists have been focused on developing a treatment option that resists bacteria and is safer than well-known traditional methods. This research led to the use of chitooligosaccharides in suppressing the growth of P. acnes, an important cause of acne, and it was discovered that it was highly effective in treating P. acnes.
The following image is from an electron microscope that reveals the effectiveness of chitooligosaccharides in resisting P. acnes bacteria.
Due to that research chitooligosaccharides have been selected to treat acne because of its high effectiveness in resisting the P. acnes bacteria without the risks associated with the use of antibiotics and other traditional medications. This is why the Dr. Rath Radiance Essence Ex uses chitooligosaccharides as an active ingredient to treat acne at its cause. When utilized as a skincare product, the ingredient is adjusted for highest efficiency while being gentle on the skin. Dr. Rath is an expert in chitooligosaccharides so you can be sure that this product delivers results.
1. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J. Cosmet. Dermatol. 2010;9:59–63. doi: 10.1111/j.1473-2165.2010.00478.x. [PubMed] [CrossRef] [Google Scholar]
2. Farrar MD, Ingham E. Acne: inflammation. Clin. Dermatol. 2004;22:380–384. doi: 10.1016/j.clindermatol.2004.03.006. [PubMed] [CrossRef] [Google Scholar]
3. Ash C, Harrison A, Drew S, Whittall R. A randomized controlled study for the treatment of acne vulgaris using high-intensity 414 nm solid state diode arrays. J. Cosmet. Laser Ther. 2015;17:170–176. doi: 10.3109/14764172.2015.1007064. [PubMed] [CrossRef] [Google Scholar]
4. Lee JH, Eom SH, Lee EH, Jung YJ, Kim HJ, Jo MR, Son KT, Lee HJ, Kim JH, Lee MS, Kim YM. In vitro antibacterial and synergistic effect of phlorotannins isolated from edible brown seaweed Eisenia bicyclis against acne-related bacteria. Algae. 2014;29:47–55. doi: 10.4490/algae.2014.29.1.047.[CrossRef] [Google Scholar]
5. Liu PF, Nakatsuji T, Zhu W, Gallo RL, Huang CM. Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris. Vaccine. 2011;29:3230–3238. doi: 10.1016/j.vaccine.2011.02.036. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
6. Han S, Lee K, Yeo J, Baek H, Park K. Antibacterial and anti-inflammatory effects of honeybee (Apis mellifera) venom against acne-inducing bacteria. J. Med. Plants Res. 2010;4:459–464.[Google Scholar]
7. Kim JY, Oh TH, Kim BJ, Kim SS, Lee NH, Hyun CG. Chemical composition and anti-inflammatory effects of essential oil from Farfugium japonicum flower. J. Oleo Sci. 2008;57:623–628. doi: 10.5650/jos.57.623. [PubMed] [CrossRef] [Google Scholar]
8. Lee SH, Ryu BM, Je JY, Kim SK. Diethylaminoethyl chitosan induces apoptosis in HeLa cells via activation caspase-3 and p53 expression. Carbohydr. Polym. 2011;84:571–578. doi: 10.1016/j.carbpol.2010.12.027. [CrossRef] [Google Scholar]
9. Kim JH, Je JY, Kim YM. Anti-inflammatory effects of chitosan-phytochemical conjugates against Propionibacterium acnes-induced inflammation. Korean J. Fish. Aquat. Sci. 2016;49:589–593.[Google Scholar]
10. Cho YS, Kim SK, Ahn CB, Je JY. Preparation, characterization, and antioxidant properties of gallic acid-grafted-chitosans. Carbohydr. Polym. 2011;83:1617–1622. doi: 10.1016/j.carbpol.2010.10.019.[CrossRef] [Google Scholar]
11. Seo S, King JM, Prinyawiwatkul W. Simultaneous depolymerization and decolorization of chitosan by ozone treatment. J. Food Sci. 2007;72:522–526. doi: 10.1111/j.1750-3841.2007.00563.x. [PubMed] [CrossRef] [Google Scholar]
12. Kim SK, Rajapakse N. Enzymatic production and biological activities of chitosan oligosaccharides (COS): a review. Carbohydr. Polym. 2005;62:357–368. doi: 10.1016/j.carbpol.2005.08.012. [CrossRef] [Google Scholar]
13. Lodhi G, Kim YS, Hwang JW, Kim SK, Jeon YJ, Je JY, Ahn CB, Moon SH, Jeon BT, Park PJ. Chitooligosaccharide and its derivatives: preparation and biological applications. BioMed Res. Int. Article ID 654913 (2014) [PMC free article] [PubMed]
14. Xia WS. Physiological activities of chitosan and its application in functional foods. J. Chinese Inst. Food Sci. Technol. 2003;3:77–81. [Google Scholar]
15. Bravo-Osuna I, Millotti G, Vauthier C, Ponchel G. In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly (isobutyl cyanoacrylate) core-shell nanoparticles. Int. J. Pharm. 2007;338:284–290. doi: 10.1016/j.ijpharm.2007.01.039. [PubMed] [CrossRef] [Google Scholar]
16. Xia W, Liu P, Zhang J, Chen J. Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloid. 2011;25:170–179. doi: 10.1016/j.foodhyd.2010.03.003. [CrossRef] [Google Scholar]
17. Park PJ, Je JY, Jung WK, Byun HG, Kim SK. Free radical scavenging activities of chitooligosaccharides hydrolyzed from chitosan with high degree of deacetylation on 1,1-diphenyl-2-picrylhydrazyl radical., J. Chitin Chitosan 9: 108–113 (2004)
18. Jung WK, Moon SH, Kim SK. Effect of chitooligosaccharides on calcium bioavailability and bone strength in ovariectomized rats. Life Sci. 2006;78:970–976. doi: 10.1016/j.lfs.2005.06.006. [PubMed] [CrossRef] [Google Scholar]
19. Grierson DS, Afolayan AJ. Antibacterial activity of some indigenous plants used for the treatment of wounds in the Eastern Cape. South Africa. J. Ethnopharmacol. 1999;66:103–106. doi: 10.1016/S0378-8741(98)00202-5. [PubMed] [CrossRef] [Google Scholar]
20. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard, 8th ed. CLSI document M07-A8. CLSI, Wayne, PA, pp 68 (2006)
21. Amyes S, Miles RS, Thomson CJ, Tillotson G. Antimicrobial Chemotherapy: Pocketbook. CRC Press, Florida, pp 25 (1996)
22. Jenkins SG, Schuetz AN. Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clin. Proc. 2012;87:290–308. doi: 10.1016/j.mayocp.2012.01.007. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 2003;52:1. doi: 10.1093/jac/dkg301. [PubMed] [CrossRef] [Google Scholar]
24. Hsieh MH, Yu CM, Yu VL, Chow JW. Synergy assessed by checkerboard. A critical analysis. Diagn. Microbiol. Infect. Dis. 1993;16:343–349. doi: 10.1016/0732-8893(93)90087-N. [PubMed] [CrossRef] [Google Scholar]
25. Kim YH, Kim JH, Kim DH, Kim SH, Kim HR, Kim YM. Synergistic Antimicrobial Effect of Sargassum serratifolium (C. Agardh) C. Agardh extract against human skin pathogens. Korea. J. Food Sci. Technol. 2016;48:241–246. [Google Scholar]
26. Rabea EI, Badawy ME, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 2003;4:1457–1465. doi: 10.1021/bm034130m.[PubMed] [CrossRef] [Google Scholar]
27. Champer J, Patel J, Fernando N, Salehi E, Wong V, Kim J. Chitosan against cutaneous pathogens. AMB Express. 2013;3:37. [PMC free article] [PubMed] [Google Scholar]
28. Shon DH. Chitosan oligosaccharides for functional foods and microbial enrichment of chitosan oligosaccharides in soy-paste. In: Proceedings of the International workshop on Bioactive Natural Products. The Committee on Science and Technology in Developing Countries (COSTED) and the Science Council of Japan, Tokyo, Japan: 56–66. (2001)
29. Tharanathan RN, Kittur FS. Chitin—The undisputed biomolecule of great potential. Crit. Rev. Food Sci. Nutr. 2003;43:61–87. doi: 10.1080/10408690390826455. [PubMed] [CrossRef] [Google Scholar]
30. Park SC, Nah JW, Park Y. pH-dependent mode of antibacterial actions of low molecular weight water-soluble chitosan (LMWSC) against various pathogens. Macromol. Res. 2011;19:853–860. doi: 10.1007/s13233-011-0812-1. [CrossRef] [Google Scholar]
31. Goy RC, Britto DD, Assis OB. A review of the antimicrobial activity of chitosan. Polimeros. 2009;19:241–247. [Google Scholar]
32. Eaton P, Fernandes JC, Pereira E, Pintado ME, Malcata FX. Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus. Ultramicroscopy. 2008;108:1128–1134. doi: 10.1016/j.ultramic.2008.04.015. [PubMed] [CrossRef] [Google Scholar]
33. Soussy CJ, Cluzel R, Courvalin P. Definition and Determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. Eur. J. Clin. Microbiol. Infect. Dis. 1994;13:238–246. doi: 10.1007/BF01974543. [PubMed] [CrossRef] [Google Scholar]
34. Eom SH, Park JH, Yu DU, Choi JI, Choi JD, Lee MS, Kim YM. Antimicrobial activity of brown alga Eisenia bicyclis against methicillin-resistant Staphylococcus aureus. Fish. Aquat. Sci. 2011;14:251–256. [Google Scholar]